Bmi1通过激活CD133+脑肿瘤起始细胞中的差异基因网络调控人胶质母细胞瘤干细胞
该研究探讨多梳家族成员BMI1在患者来源的胶质母细胞瘤脑肿瘤起始细胞(BTICs)中的作用及其与CD133的关系。通过Bmi1功能获得与缺失实验,评估神经干细胞和GBM BTICs的体外自我更新与体内成瘤能力,并对Bmi1敲低的BTIC群体进行RNA测序以探索BMI1转录调控网络。结果显示BMI1在CD133阳性细胞中具有差异作用,尤其涉及细胞代谢,并鉴定出ITGA2等关键下游靶点,可能调控GBM干细胞特性。
要点
- BMI1在CD133+ GBM BTICs中通过差异基因网络调控干细胞特性。
- BMI1下游靶点ITGA2可能影响GBM干细胞特性。
- CD133-BMI1环路相关基因或为克服治疗抵抗提供潜在靶点。
核心结论
- BMI1在CD133阳性GBM BTICs中通过激活差异基因网络调控肿瘤起始细胞特性。
- BMI1下游效应分子如ITGA2可能成为针对GBM治疗抵抗细胞群体的未来靶点。
研究设计与样本
- 对神经干细胞进行Bmi1功能获得研究,对患者来源GBM BTICs进行Bmi1功能缺失研究。
- 体外评估自我更新,体内评估成瘤能力。
- 对Bmi1敲低的不同GBM BTIC群体进行RNA测序以探索BMI1转录调控网络。
主要发现
- BMI1在CD133阳性细胞中具有差异作用,尤其涉及细胞代谢。
- 在CD133+细胞中鉴定出BMI1下游关键靶点包括整合素α2(ITGA2)。
- ITGA2可能参与调控GBM干细胞特性。
临床怎么用
- 关注CD133+ BTICs中BMI1-ITGA2轴作为潜在治疗靶点。
- BMI1在CD133+细胞中的代谢相关差异作用值得进一步转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glioblastoma (GBM) is the most aggressive adult brain cancer, with a 15 month median survivorship attributed to the existence of treatment-refractory brain tumor initiating cells (BTICs). In order to better understand the mechanisms regulating the tumorigenic properties of this population, we studied the role of the polycomb group member BMI1 in our patient-derived GBM BTICs and its relationship with CD133, a well-established marker of BTICs. METHODS: Using gain and loss-of-function studies for Bmi1 in neural stem cells (NSCs) and patient-derived GBM BTICs respectively, we assessed in vitro self-renewal and in vivo tumor formation in these two cell populations. We further explored the BMI1 transcriptional regulatory network through RNA sequencing of different GBM BTIC populations that were knocked down for Bmi1. RESULTS: There is a differential role of BMI1 in CD133-positive cells, notably involving cell metabolism. In addition, we identified pivotal targets downstream of BMI1 in CD133+ cells such as integrin alpha 2 (ITGA2), that may contribute to regulating GBM stem cell properties. CONCLUSIONS: Our work sheds light on the association of three genes with CD133-BMI1 circuitry, their importance as downstream effectors of the BMI1 signalling pathway, and their potential as future targets for tackling GBM treatment-resistant cell populations.
引用
- Vora P, Seyfrid M, Venugopal C, et al. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. J Neurooncol. 2019. PMID: 31115870. doi:10.1007/s11060-019-03192-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。